Skip to main content

Closed

TCRT: Alaunos Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-50.0% / yr

Operating margin-138166.6%

ROIC-321.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio1.63×

Alaunos Therapeutics, Inc.

TCRTNASDAQ Global Select·USD·Closed

Alaunos Therapeutics, Inc.

TCRTNASDAQ·USD·Closed

$1.88

+0.00%

$1.88

+$0.00 (0.00%)

52W Range

7thpctl

Volume

0.59×avg

Mkt Cap

4.59MUSD

P/E

-0.9TTM

Div Yield

–ann

52W Range

7thpctl

Volume

0.59×avg

Market Cap

4.59MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings